[1] Rahman R, Simoes EJ, Schmaltz C, et al. Trend analysis and survival of primary gallbladder cancer in the United States: a 19732009 populationbased study[J]. Cancer Med, 2017, 6(4): 874-880. DOI: 10.1002/cam4.1044.
[2] Shen HX, Song HW, Xu XJ, et al. Clinical epidemiological survey of gallbladder carcinoma in northwestern China, 2009-2013: 2379 cases in 17 centers[J]. Chronic Dis Transl Med, 2017, 3(1): 60-66. DOI: 10.1016/j.cdtm.2017.01.003.
[3] Sotwiński R, Lech G, Sotwińska SM. MicroRNAs in pancreatic cancer diagnosis and therapy[J]. Cent Eur J Immunol, 2018, 43(3): 314-324. DOI: 10.5114/ceji.2018.80051.
[4] Liu J, Bian T, Feng J, et al. miR-335 inhibited cell proliferation of lung cancer cells by target Tra2β[J]. Cancer Sci, 2018, 109(2): 289-296. DOI: 10.1111/cas.13452.
[5] Cao H, Huang S, Liu A, et al. Up-regulated expression of miR155 in human colonic cancer[J]. J Cancer Res Ther, 2018, 14(3): 604-607. DOI: 10.4103/0973-1482.175432.
[6] Kai D, Yannian L, Yitian C, et al. Circular RNA HIPK3 promotes gallbladder cancer cell growth by sponging microRNA124[J]. Biochem Biophys Res Commun, 2018, 503(2): 863-869. DOI: 10.1016/j.bbrc.2018.06.088.
[7] Wang F, Li L, Piontek K, et al. Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma[J]. Hepatology, 2018, 67(3): 940-954. DOI: 10.1002/hep.29586.
[8] Khalighfard S, Alizadeh AM, Irani S, et al. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients[J]. Sci Rep, 2018, 8(1): 17981. DOI: 10.1038/s41598-018-36321-3.
[9] Yang L, Huang S, Ma H, et al. MicroRNA125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer[J]. Tumour Biol, 2017, 39(3): 1010428317692249. DOI: 10.1177/1010428317692249.
[10] 束翌俊, 江林, 包润发, 等. MiR29c5p在胆囊癌组织中的表达及临床意义[J].中华普通外科杂志, 2015, 30(9): 715-718. DOI: 10.3760/cma.j.issn.1007631X.2015.09.014.
[11] Yang G, Zhang L, Li R, et al. The role of microRNAs in gallbladder cancer[J]. Mol Clin Oncol, 2016, 5(1): 7-13. DOI: 10.3892/mco.2016.905.
[12] Peng HH, Zhang YD, Gong LS, et al. Increased expression of microRNA335 predicts a favorable prognosis in primary gallbladder carcinoma[J]. Onco Targets Ther, 2013, 6(11): 1625-1630. DOI: 10.2147/OTT.S53030.
[13] Kono H, Nakamura M, Ohtsuka T, et al. High expression of microRNA155 is associated with the aggressive malignant behavior of gallbladder carcinoma[J]. Oncol Rep, 2013, 30(1): 17-24. DOI: 10.3892/or.2013.2443.
[14] Zhang XL, Chen JH, Qin CK. MicroRNA155 expression as a prognostic factor in patients with gallbladder carcinoma after surgical resection[J]. Int J Clin Exp Med, 2015, 8(11): 21241-21246.
[15] 韩超, 王健东. 非编码微小RNA在胆囊癌中的表达及功能[J]. 中华消化外科杂志, 2015, 14(10): 877-880. DOI: 10.3760/cma.j.issn.1673-9752.2015.10.021.
[16] Lv YP, Shi W, Liu HX, et al. Identification of miR146b5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma[J]. Eur Rev Med Pharmacol Sci, 2017, 21(3): 518-522. |